The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | Anderson Robert Eugene Jr | Director | Buy(P) | 9K | $2.90 | $25K |
| Nov 20, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 150K | $2.76 | $414K |
| Nov 19, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 73K | $2.75 | $202K |
| Oct 21, 2025 | Bir Dawn Carter | Director | Grant(A) | 53K | — | $0 |
| Sep 30, 2025 | Cook Robert Christopher | Chief Operating & Legal Office | Buy(P) | 14K | $2.91 | $40K |
| Sep 22, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 7K | $2.28 | $16K |
| Sep 19, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 400 | $2.25 | $900 |
| Sep 19, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 47K | $2.29 | $107K |
| Sep 18, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 5K | $2.13 | $12K |
| Sep 18, 2025 | Barry Richard | President & CEO, Director | Buy(P) | 185K | $2.24 | $415K |
| May 23, 2025 | Scannon Patrick J MD PHD | Director | Grant(A) | 27K | — | $0 |
| May 23, 2025 | O Donnell Michael J | Director | Grant(A) | 27K | — | $0 |
| May 23, 2025 | Nicaise Claude | Director | Grant(A) | 27K | — | $0 |
| May 23, 2025 | Gussin Robert Z | Director | Grant(A) | 27K | — | $0 |
| May 23, 2025 | Gravier Pierre | Director | Grant(A) | 27K | — | $0 |
| May 23, 2025 | Anderson Robert Eugene Jr | Director | Grant(A) | 27K | — | $0 |
| Apr 17, 2025 | Cook Robert Christopher | Chief Operating & Legal Office | Grant(A) | 100K | — | $0 |
| Apr 17, 2025 | Nassif Freda | Chief Business Officer | Grant(A) | 100K | — | $0 |
| Apr 17, 2025 | Barry Richard | President & CEO, Director | Grant(A) | 350K | — | $0 |
| Apr 17, 2025 | Schoen Eric | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Nov 29, 2024 | Schoen Eric | Chief Financial Officer | Option exercise(M) | 50K | $1.18 | $59K |
| Nov 29, 2024 | Schoen Eric | Chief Financial Officer | Sell(S) | 2K | $3.82 | $8K |
| Nov 29, 2024 | Schoen Eric | Chief Financial Officer | Sell(S) | 60K | $3.86 | $231K |
| Nov 29, 2024 | Schoen Eric | Chief Financial Officer | Option exercise(M) | 50K | — | $0 |
| Nov 29, 2024 | Kupiec James William | Chief Medical Officer | Sell(S) | 4K | $3.87 | $15K |
| Nov 18, 2024 | Nassif Freda | Chief Commercial Officer | Grant(A) | 100K | — | $0 |
| Nov 18, 2024 | Landen Jaren | Chief Clinical Dev. Officer | Grant(A) | 85K | — | $0 |
| Oct 1, 2024 | Barry Richard | President & CEO, Director | Grant(A) | 600K | — | $0 |
| Sep 6, 2024 | Kupiec James William | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Sep 6, 2024 | Cook Robert Christopher | SVP & General Counsel | Grant(A) | 100K | — | $0 |
| Sep 6, 2024 | Schoen Eric | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| May 20, 2024 | Kupiec James William | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| May 20, 2024 | Cook Robert Christopher | SVP & General Counsel | Grant(A) | 10K | — | $0 |
| May 20, 2024 | Schoen Eric | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| May 20, 2024 | Barbier Remi | President & CEO, Director | Grant(A) | 50K | — | $0 |
| May 16, 2024 | Robertson Sanford | Director | Gift(G) | 5K | — | $0 |
| May 16, 2024 | Robertson Sanford | Director | Gift(G) | 5K | — | $0 |
| May 9, 2024 | Nicaise Claude | Director | Grant(A) | 10K | — | $0 |
| May 9, 2024 | Gravier Pierre | Director | Grant(A) | 10K | — | $0 |
| May 9, 2024 | Anderson Robert Eugene Jr | Director | Grant(A) | 10K | — | $0 |
| May 9, 2024 | Scannon Patrick J MD PHD | Director | Grant(A) | 10K | — | $0 |
| May 9, 2024 | Robertson Sanford | Director | Grant(A) | 15K | — | $0 |
| May 9, 2024 | Barry Richard | Director | Grant(A) | 15K | — | $0 |
| May 9, 2024 | O Donnell Michael J | Director | Grant(A) | 10K | — | $0 |
| May 9, 2024 | Gussin Robert Z | Director | Grant(A) | 15K | — | $0 |
| Apr 26, 2024 | Robertson Sanford | Director | Option exercise(M) | 69K | $22.00 | $1.5M |
| Apr 26, 2024 | Robertson Sanford | Director | Option exercise(M) | 46K | — | $0 |
| Apr 23, 2024 | Barry Richard | Director | Option exercise(M) | 176K | $22.00 | $3.9M |
| Apr 23, 2024 | Barry Richard | Director | Option exercise(M) | 117K | — | $0 |
| Apr 18, 2024 | Kupiec James William | Chief Medical Officer | Option exercise(M) | 2K | $22.00 | $33K |
| Apr 18, 2024 | Kupiec James William | Chief Medical Officer | Option exercise(M) | 1K | — | $0 |
| Apr 17, 2024 | Schoen Eric | Chief Financial Officer | Option exercise(M) | 2K | $22.00 | $33K |
| Apr 17, 2024 | Schoen Eric | Chief Financial Officer | Option exercise(M) | 1K | — | $0 |
| Jan 3, 2024 | Schoen Eric | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Jan 3, 2024 | Schoen Eric | Chief Financial Officer | Grant(A) | 800 | — | $0 |
| Jan 3, 2024 | Kupiec James William | Chief Medical Officer | Grant(A) | 1K | — | $0 |
| Jan 3, 2024 | Barry Richard | Director | Grant(A) | 117K | — | $0 |
| Jan 3, 2024 | Robertson Sanford | Director | Grant(A) | 355K | — | $0 |
| Jan 3, 2024 | Robertson Sanford | Director | Grant(A) | 72K | — | $0 |
| Dec 6, 2023 | Anderson Robert Eugene Jr | Director | Grant(A) | 20K | — | $0 |
| Dec 6, 2023 | Gravier Pierre | Director | Grant(A) | 20K | — | $0 |
| Dec 6, 2023 | Nicaise Claude | Director | Grant(A) | 20K | — | $0 |
| Oct 3, 2023 | Barbier Remi | President & CEO, Director | Grant(A) | 150K | — | $0 |
| Oct 3, 2023 | Barbier Remi | President & CEO, Director | Grant(A) | 300K | — | $0 |
| Oct 3, 2023 | Kupiec James William | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Oct 3, 2023 | Cook Robert Christopher | SVP & General Counsel | Grant(A) | 50K | — | $0 |
| Oct 3, 2023 | Schoen Eric | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Aug 23, 2023 | Robertson Sanford | Director | Buy(P) | 30K | $17.45 | $524K |
| Aug 22, 2023 | Barry Richard | Director | Buy(P) | 17K | $16.65 | $276K |
| Aug 21, 2023 | Barry Richard | Director | Buy(P) | 2K | $16.80 | $32K |
| Jun 12, 2023 | Scannon Patrick J MD PHD | Director | Option exercise(M) | 1K | $0.95 | $950 |
| Jun 12, 2023 | Scannon Patrick J MD PHD | Director | Option exercise(M) | 1K | $0.95 | $950 |
| May 24, 2023 | Barbier Remi | President and CEO, Director | Tax withholding(F) | 10K | $25.25 | $241K |
| May 24, 2023 | Barbier Remi | President and CEO, Director | Option exercise(M) | 71K | $16.87 | $1.2M |
| May 24, 2023 | Barbier Remi | President and CEO, Director | Tax withholding(F) | 48K | $25.25 | $1.2M |
| May 24, 2023 | Barbier Remi | President and CEO, Director | Option exercise(M) | 14K | $16.87 | $241K |
| May 24, 2023 | Barbier Remi | President and CEO, Director | Option exercise(M) | 71K | $16.87 | $1.2M |
| May 24, 2023 | Barbier Remi | President and CEO, Director | Option exercise(M) | 14K | $16.87 | $241K |
| May 10, 2023 | Robertson Sanford | Director | Option exercise(M) | 4K | $16.66 | $59K |
| May 10, 2023 | Robertson Sanford | Director | Option exercise(M) | 4K | $19.60 | $70K |
| May 10, 2023 | Robertson Sanford | Director | Option exercise(M) | 2K | $16.66 | $36K |
| May 10, 2023 | Robertson Sanford | Director | Option exercise(M) | 4K | $19.60 | $70K |
| May 10, 2023 | Robertson Sanford | Director | Option exercise(M) | 4K | $16.66 | $59K |
| May 10, 2023 | Robertson Sanford | Director | Option exercise(M) | 2K | $16.66 | $36K |
| May 4, 2023 | Barry Richard | Director | Grant(A) | 5K | $22.34 | $112K |
| May 4, 2023 | Barry Richard | Director | Grant(A) | 20K | $22.34 | $447K |
| May 4, 2023 | Gussin Robert Z | Director | Grant(A) | 5K | $22.34 | $112K |
| May 4, 2023 | Gussin Robert Z | Director | Grant(A) | 20K | $22.34 | $447K |
| May 4, 2023 | O Donnell Michael J | Director | Grant(A) | 20K | $22.34 | $447K |
| May 4, 2023 | Robertson Sanford | Director | Grant(A) | 5K | $22.34 | $112K |
| May 4, 2023 | Robertson Sanford | Director | Grant(A) | 20K | $22.34 | $447K |
| May 4, 2023 | Scannon Patrick J MD PHD | Director | Grant(A) | 20K | $22.34 | $447K |
| May 1, 2023 | Gussin Robert Z | Director | Option exercise(M) | 4K | $19.60 | $70K |
| May 1, 2023 | Gussin Robert Z | Director | Option exercise(M) | 4K | $16.66 | $59K |
| May 1, 2023 | Gussin Robert Z | Director | Option exercise(M) | 2K | $16.66 | $36K |
| May 1, 2023 | Gussin Robert Z | Director | Tax withholding(F) | 7K | $23.34 | $165K |
| May 1, 2023 | Gussin Robert Z | Director | Option exercise(M) | 4K | $19.60 | $70K |
| May 1, 2023 | Gussin Robert Z | Director | Option exercise(M) | 4K | $16.66 | $59K |
| May 1, 2023 | Gussin Robert Z | Director | Option exercise(M) | 2K | $16.66 | $36K |
| Mar 7, 2023 | Barry Richard | Director | Buy(P) | 77K | $25.76 | $2.0M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).